Universidad Autonoma de Baja California Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2014
NCT02815189
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Universidad Autonoma de Baja California

Active Ingredients

Drugs in Phase 2 Trials (2)

acetaminophen (tylenol) (1 trial)

ibuprofen (motrin) (1 trial)

Drugs in Other Trials (3)

diclofenac (voltaren) (1 trial)

ketorolac (acuvail) (1 trial)

spirulina maxima (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5